Pangaea Talk Radio

The Infectious Diseases Institute in Kampala, Uganda: Lessons learned in the creation of an HIV/AIDS clinic and training center in the developing world

Chuck Wilson
Chuck Wilson
Julia Martin
Julia Martin
Pangaea President Pat Christen interviews Chuck Wilson, Operations, Fiscal and Construction Manager, and Julia Martin, Manager of Programs and Personnel, about the development at the Infectious Diseases Institute (“IDI”) at Makerere University in Kampala, Uganda; recorded on May 24, 2004

Pangaea’s Julia Martin and Chuck Wilson have played a key role in the creation and development of the new Infectious Diseases Institute (“IDI”) at Makerere University in Kampala, Uganda. This facility, which is scheduled to be fully operational in October of 2004, will serve as both an HIV/AIDS clinic serving thousands of patients every month and a regional HIV clinical training center for physicians and nurses. Its founders, the physicians of the Academic Alliance for AIDS Care and Prevention in Africa (“Academic Alliance”), believe that the IDI will serve as a model for the treatment and prevention of AIDS in a resource-limited environment. Chuck and Julia, who have been overseeing the project for the last three years, provide a unique, on-the-ground perspective about what it takes to develop medical infrastructure in the developing world. Listen >

Pangaea Talk Radio

Creating a State-of-the-Art HIV/AIDS Clinic and Training Center in Uganda

Paula Luff
Paula Luff
Barbara Lawson
Barbara Lawson
Pangaea President Pat Christen interviews Paula Luff, Director of International Philanthropy for Pfizer Foundation and Pfizer Inc, and Barbara Lawson, Project Director for Pangaea; recorded on April 7, 2004

Pfizer Inc has provided funding for the construction and development of the new Infectious Diseases Institute (“IDI”) at Makerere University in Kampala, Uganda. This facility, which is scheduled to be fully operational in October of 2004, will serve as both a regional HIV clinical training center for physicians and nurses and as a model for the treatment and prevention of AIDS, including the provision of HIV antiretroviral drugs (ARVs), in a resource-limited environment. The IDI is a product of a partnership between the Academic Alliance for AIDS Care and Prevention in Africa, Pangaea, and Pfizer, which provided an initial $11 million construction and program grant for the project. Listen >

Pangaea